PT  - JOURNAL ARTICLE
AU  - Kuznar, Wayne
ED  - Fasching, Peter
TI  - In Real-World Settings, EVE and EXE Extend PFS in Breast Cancer: BRAWO
DP  - 2014 Dec 01
TA  - MD Conference Express
PG  - 22--22
VI  - 14
IP  - 36
4099  - http://mdc.sagepub.com/content/14/36/22.short
4100  - http://mdc.sagepub.com/content/14/36/22.full
AB  - Administration of everolimus (combined with exemestane in real-world conditions extends progression-free survival in postmenopausal women with hormone receptor-positive advanced breast cancer. Data from the German Breast Cancer Treatment With Afinitor (Everolimus) and Exemestane for ER+ Women trial [BRAWO] are discussed in this article.